Stocks Hitting 52-Week Lows

shares fell 2.22 percent to touch a new 52-week low of $7.91. Mirati Therapeutics shares have dropped 73.94 percent over the past 52 weeks, while the S&P 500 index has increased 0.09 percent in the same period.

shares touched a new 52-week low of $1.63 as the company reported top-line results from Phase 3 trial in adult focal onset seizures. In this trial, ganaxolone did not meet the primary endpoint.

shares reached a new 52-week low of $9.415. CVR Refining shares have tumbled 47.86 percent over the past 52 weeks, while the S&P 500 index has gained 0.09 percent in the same period.

shares fell 2.02 percent to touch a new 52-week low of $50.44. Luxottica shares have declined 24.18 percent over the past 52 weeks, while the S&P 500 index has gained 0.09 percent in the same period.